<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>4
<FILENAME>zynex8kex991_3202006.txt
<TEXT>
                                                                    Exhibit 99.1

FOR IMMEDIATE RELEASE:
----------------------

ZYNEX RECEIVES INCREASE IN CREDIT FACILITY TO FINANCE GROWTH LITTLETON, Colo.,
March 17, 2006 - Zynex Medical Holdings, Inc. (OTCBB: ZYNX), a provider of pain
management systems and electrotherapy products for medical patients with
functional disability, today announced that Silicon Valley Bank, the primary
operating subsidiary of SVB Financial Group (NASDAQ: SIVB), has increased the
Company's credit facility by $240,000 to $600,000. The Company will use the
additional funds for working capital. "The availability of an additional
$240,000 in funding will enable Zynex to further ramp up our sales, marketing
and support efforts in Europe and domestically for our NeuroMove(TM) Stroke
Recovery System and related products," stated Zynex President and Chief
Executive Officer Thomas Sandgaard.

The NeuroMove(TM) system increases the functionality of many stroke victims by
teaching the healthy parts of the brain to compensate for damaged areas. The
NeuroMove(TM), which is significantly more sensitive than most diagnostic
equipment, monitors muscle activity and selects signals from the brain
indicating that the patient is attempting to move a certain muscle. It then
introduces the actual movement through electrical stimulation. Eventually the
connection between the brain and muscle can often be reestablished. The
NeuroMove(TM) (www.neuromove.com) also can be used to treat spinal cord
injuries.

About Zynex

Zynex Medical Holdings, Inc., (www.zynexmed.com), a leading provider of
therapeutic devices for patients with functional disability through the
creation, distribution, and marketing of electrotherapy devices since 1996,
strives to uphold its mission to improve the quality of life of patients
suffering from debilitating pain or illness by providing innovative technology.
Utilizing a unique combination of electromyographic (EMG) technology combined
with a system of instruction and reinforcement, including electrical muscle
stimulation (EMS), Zynex offers new treatment options to post-stroke and spinal
injury patients.

About Silicon Valley Bank

Silicon Valley Bank provides diversified financial services to emerging growth
and mature companies in the technology, life science, private equity and premium
wine industries. Through its focus on specialized markets and extensive
knowledge of the people and business issues driving them, Silicon Valley Bank
provides a level of service and partnership that measurably impacts its clients'
success. Founded in 1983 and headquartered in Santa Clara, Calif., the company
serves more than 10,000 clients around the world through 27 domestic offices and
two international subsidiaries in the U.K. and India, and an extensive network
of relationships with venture capitalists around the world. More information on
the company can be found at www.svb.com. Thomas Sandgaard President and Chief
Executive Officer 303-703-4906 or Ron Stabiner The Wall Street Group, Inc.
212-888-4848 2

Safe Harbor Provision

Certain statements in this release are "forward-looking" and as such are subject
to numerous risks and uncertainties. Actual results may vary significantly from
the results expressed or implied in such statements. Factors that could cause
actual results to materially differ from forward-looking statements include, but
are not limited to, the Company's ability to meet terms and conditions required
to obtain project financing, risks and delays associated with product
development, risk of market acceptance of new products, technology or product
obsolescence, competitive risks, reliance on development partners and additional
capital needs.


                                      # # #

</TEXT>
</DOCUMENT>
